Lucinactant: A new solution in treating neonatal respiratory distress syndrome NRDS
Journal Title: International Journal of Allied Medical Sciences and Clinical Research - Year 2014, Vol 2, Issue 2
Abstract
Lucinactant is a novel synthetic surfactant, approved by the FDA on March 6th 2012, for use in treatment of RDS. It’s superiority as compared to the previously approved surfactants lie in containing sinapultide, a 21- amino acid peptide also known as KL4 peptide, which has been designed to mimic the activity of human surfactant protein. Lucinactant is completely devoid of any animal derived components. It is the fifth drug approved by the FDA for the treatment of RDS. It has shown immense efficacy in phase two clinical trials and animal model studies and exhibited better efficiency when compared to other surfactants in both 24 hour and two week mortality rates of infants in RDS. Lucinactant tends reduce the surface tension at the air-liquid interface of alveolar surfaces and allows lungs to function normally. It was observed that the side effects were lesser with Lucinactant when compared with other naturally derived surfactants.
Authors and Affiliations
Raafia Yousuf
Keywords
Related Articles
- EP ID EP417464
- DOI -
- Views 60
- Downloads 0
Added effect of muscle energy technique on improving functional ability in frozen shoulder
Background and Objectives In Frozen Shoulder patients have a painful loss of shoulder motion with development of dense adhesions, capsular thickening and capsular restrictions, especially in the dependent folds of the ca...
A case report on Pre-B Acute Lymphoblastic Leukemi
Lymphoid leukemias are a group of leukemias affecting circulating lymphocytes. Acute lymphoblastic leukemia (ALL) is a malignant disease of the bone marrow in which early lymphoid precursors proliferate and replace the n...
Potential ointment of carica papaya leaf extract against postpartum perineal wounds healing first: experimental study in galuh wistar mice (rattus norvegicus)
Background Perineal rupture occurs in about 85% of vaginal deliveries. If the wound is not treated properly, it causes pain and infection which prevents wound healing. Perineal wound care in addition to using 10% povidon...
Hepatocellular carcinoma: An overview of disease epidemiology and risk factors
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Consequently, the epidemiology of this fatal disease is well considered and studied. Although hepatitis B virus (HBV) and hepatitis C virus (HCV)...
Thrombocyte: the prime target of dengue virus – A review
Dengue fever is an endemic infectious disease caused by dengue virus (DENV). A sustained increase in the incidence of dengue infection is clear in tropical and subtropical areas of the world. Clinical manifestations in d...